Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Phytotherapy Research : PTR|November 6, 2015
Artepillin C and Other Herbal PAK1-blockers: Effects on Hair Cell Proliferation and Related PAK1-dependent Biological Function in Cell CultureBinh Cao Quan Nguyen, Nozomi Taira, Hiroshi Maruta, et al.
Cell Cycle (Georgetown, Tex.)|December 6, 2003
PAK is essential for RAS-induced upregulation of cyclin D1 during the G1 to S transitionThao Nheu, Hong He, Yumiko Hirokawa, et al.
International Journal of Surgery Case Reports|July 31, 2021
Transanal approach after preoperative imatinib treatment of a rectal gastrointestinal stromal tumors with external anal sphincter invasion: A case reportMakoto Hisanaga, Takashi Nonaka, Hiroshi Maruta, et al.
Drug Discoveries & Therapeutics|April 27, 2017
Frondoside A from sea cucumber and nymphaeols from Okinawa propolis: Natural anti-cancer agents that selectively inhibit PAK1 in vitroBinh Cao Quan Nguyen, Kazuki Yoshimura, Shigenori Kumazawa, et al.
Drug Discoveries & Therapeutics|September 16, 2015
Combination of immunoprecipitation (IP)-ATP_Glo kinase assay and melanogenesis for the assessment of potent and safe PAK1-blockers in cell cultureBinh Cao Quan Nguyen, Pham Thi Be Tu, Shinkichi Tawata, et al.
Cancer Letters|March 17, 2006
Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors)Yumiko Hirokawa, Alexander Levitzki, Guillaume Lessene, et al.
Drug Discoveries & Therapeutics|April 27, 2017
1,2,3-Triazolyl esterization of PAK1-blocking propolis ingredients, artepillin C (ARC) and caffeic acid (CA), for boosting their anti-cancer/anti-PAK1 activities along with cell-permeabilityHideaki Takahashi, Binh Cao Quan Nguyen, Yoshihiro Uto, et al.
European Journal of Medicinal Chemistry|November 28, 2016
1,2,3-Triazolyl ester of Ketorolac: A "Click Chemistry"-based highly potent PAK1-blocking cancer-killerBinh Cao Quan Nguyen, Hideaki Takahashi, Yoshihiro Uto, et al.
Cancer Biology & Therapy|April 23, 2005
Signal therapy of NF1-deficient tumor xenograft in mice by the anti-PAK1 drug FK228Yumiko Hirokawa, Hidenori Nakajima, C Oliver Hanemann, et al.
Drug Discoveries & Therapeutics|January 16, 2018
Both triazolyl ester of ketorolac (15K) and YM155 inhibit the embryonic angiogenesis in ovo (fertilized eggs) via their common PAK1-survivin/VEGF signaling pathwayMok-Ryeon Ahn, Ji-Yeon Bae, Da-Hye Jeong, et al.
Pageof 4